Serum Institute of India gets DCGI nod for skin test kit for latent TB diagnosis Ruchika Sharma12 May 2022 12:44 PM ISTPune-based firm Mylab has partnered with the SII for this kit, an official source said.
CDSCO allows import of drugs with residual shelf life less than 60 percent till October 31, 2021 Susmita Roy8 May 2022 12:00 PM ISTNew Delhi: With an aim to ensure drug availability in sufficient quantity in the domestic market, the apex drug regulator, Central Drugs Standard...
COVID vaccine for children: IAP expert comment Ananya Shrivastava7 May 2022 5:34 PM ISTIndian Academy of Paediatrics, twin cities branch, applauded the decision of the Drug Controller General of India (DCGI) which recently approved a...
Health Bulletin 6/May/2022 Roshni Dhar6 May 2022 5:25 PM ISTHere are the top health stories for the day:India stands well prepared to manage the rise in COVID-19 cases In India, we saw a...
Bharat Biotech seeks DCGI nod for phase 2/3 Covaxin booster trial for 2-18 age group Ruchika Sharma5 May 2022 12:34 PM ISTThe study is likely to be conducted at six sites, including AIIMS Delhi and Patna.
Bharat Biotech must address WHO's Covaxin suspension to avoid emergency use approval cancellation: MEA Ruchika Sharma29 April 2022 10:00 AM ISTThe communication stated that a proper response or policy from the government needs to be formulated on the issue and on further pursuance of...
DCGI grants emergency use nod to Covaxin, Corbevax, ZycovD for children Dr. Nandita Mohan27 April 2022 5:43 PM ISTThe Drugs Controller General of India (DCGI) on Tuesday approved three Covid vaccines for the restricted emergency use authorisation (EUA) for...
Health Bulletin 27/April/2022 Dr. Nandita Mohan27 April 2022 4:58 PM ISTHere are the top health stories for the day :NMC denies permission to 3 Medical Colleges, 550 MBBS seats lostFinding major deficiencies in three major...
GSK launches single inhaler-triple therapy Trelegy Ellipta to treat COPD in India Ruchika Sharma27 April 2022 11:53 AM ISTTrelegy is delivered via the innovative Ellipta inhaler that provides accurate dosing through its consistent dose delivery mechanism and is associated...
Coronavirus vaccine: DCGI grants emergency use nod to Covaxin, Corbevax, ZycovD for different age group of children MD Bureau26 April 2022 5:00 PM ISTDCGI approved restricted use for emergency situation to ZycovD for children above the age of 12 years for a two-dose regimen.
Shilpa Biologicals gets NoC to conduct trials of biosimilar Aflibercept Ruchika Sharma26 April 2022 3:55 PM ISTBiosimilar Aflibercept is the second biosimilar product from SML that has entered the clinical trial phase after Biosimilar Adalimumab.
DCGI panel asks Bharat Biotech to provide additional data on Covaxin for 2-12 years old Ruchika Sharma23 April 2022 2:49 PM ISTNo recommendations have been made as of now, sources told ANI.
